tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Karen Koski, 6 are a HOLD (60%), 1 are a SELL (10%), 3 are a BUY (30%).
Analyst Karen Koski, currently employed carries an average stock price target met ratio of 83.33% that have a potential upside of 30.31% achieved within 193 days.
Karen Koski’s has documented 15 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AXDX, Accelerate Diagnostics at 08-Oct-2020.
Analyst best performing recommendations are on AXDX (ACCELERATE DIAGNOSTICS).
The best stock recommendation documented was for AXDX (ACCELERATE DIAGNOSTICS) at 8/9/2016. The price target of $260 was fulfilled within 36 days with a profit of $40 (18.18%) receiving and performance score of 5.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$5
$3.92 (362.96%)
$3
3 months 25 days ago
(30-Jul-2024)
6/6 (100%)
$0.11 (2.25%)
16
Hold
1 years 3 months 9 days ago
(15-Aug-2023)
3/4 (75%)
$-3.75 (-34.88%)
38
Hold
$7500
2 years 4 months 17 days ago
(07-Jul-2022)
3/5 (60%)
$3649 (94.75%)
390
Buy
$15000
4 years 19 days ago
(05-Nov-2020)
1/1 (100%)
$7050 (88.68%)
177
Hold
$200
$194.55 (3569.72%)
$200
7 years 6 months 17 days ago
(08-May-2017)
2/3 (66.67%)
$64.67 (8.94%)
172
What Year was the first public recommendation made by Karen Koski?
